We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$259B
AUM Growth
+$31.2B
Cap. Flow
+$19.7B
Cap. Flow %
7.63%
Top 10 Hldgs %
24.01%
Holding
10,422
New
1,312
Increased
3,605
Reduced
3,645
Closed
1,693

Sector Composition

Rank Sector Weight
1 Technology 2.38%
2 Consumer Discretionary 1.42%
3 Communication Services 1.04%
4 Healthcare 0.74%
5 Financials 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSBC icon
9701
WesBanco
WSBC
$3.91B
-5,976
Closed -$236K
WSM icon
9702
Williams-Sonoma
WSM
$28B
-56,982
Closed -$1.32M
WST icon
9703
CALL
West Pharmaceutical
WST
$24.9B
-10,200
Closed -$964K
WTFC icon
9704
Wintrust Financial
WTFC
$10.3B
-4,347
Closed -$323K
WTS icon
9705
Watts Water Technologies
WTS
$12.4B
-11,262
Closed -$724K
WTS icon
9706
PUT
Watts Water Technologies
WTS
$12.4B
-27,500
Closed -$1.74M
WWD icon
9707
Woodward
WWD
$19.7B
-28,781
Closed -$2.03M
WWR icon
9708
Westwater Resources
WWR
$74.5M
-385
Closed -$29K
WWW icon
9709
Wolverine World Wide
WWW
$1.71B
-7,752
Closed -$211K
XEL icon
9710
CALL
Xcel Energy
XEL
$48.3B
-36,700
Closed -$1.68M
XENE icon
9711
Xenon Pharmaceuticals
XENE
$5.86B
-19,277
Closed -$61K
XPH icon
9712
CALL
State Street SPDR S&P Pharmaceuticals ETF
XPH
$563M
-11,400
Closed -$491K
XPL icon
9713
Solitario Resources
XPL
$75.1M
-50,947
Closed -$34K
XRLV
9714
DELISTED
Invesco S&P 500 ex-Rate Sensitive Low Volatility ETF
XRLV
-21,760
Closed -$666K
YORW icon
9715
PUT
York Water
YORW
$561M
-7,400
Closed -$258K
ZEUS
9716
DELISTED
Olympic Steel
ZEUS
-11,712
Closed -$215K
ZSL icon
9717
ProShares UltraShort Silver
ZSL
$59.6M
-320
Closed -$1.67M
ZWS icon
9718
PUT
Zurn Elkay Water Solutions
ZWS
$8.1B
-115,426
Closed -$1.29M
AIOT
9719
PowerFleet Inc
AIOT
$404M
-19,383
Closed -$128K
TXNM
9720
TXNM Energy Inc
TXNM
$5.88B
-28,408
Closed -$1.09M
UCB
9721
United Community Banks
UCB
$4.27B
-18,500
Closed -$514K
INVX
9722
CALL
Innovex International
INVX
$2B
-8,100
Closed -$395K
INVX
9723
PUT
Innovex International
INVX
$2B
-32,000
Closed -$1.56M
IRD
9724
Opus Genetics
IRD
$335M
-21,163
Closed -$2.9M
PHLT
9725
CALL
DELISTED
Performant Healthcare Inc
PHLT
-15,300
Closed -$32K

Similar funds

Jeff Yass's Q3 2017 Portfolio in Review

As of Q3 2017, Jeff Yass held 10,422 positions worth $259B, up 14% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass deployed $19.7B of net new capital in Q3 2017, opening 1,312 new positions and adding to 3,605 existing holdings. Its largest new stake was JPMorgan Chase: 794,224 shares worth $75.9M.

By sector, the portfolio is most concentrated in Technology at 2.4% of assets, up from 2% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $474M trimmed.

  • Jeff Yass's largest Q3 2017 buy was JPMorgan Chase: 794,224 shares worth $75.9M.
  • Jeff Yass added most to Apple in Q3 2017, an estimated $1.31B increase.
  • Jeff Yass's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $474M.
  • Jeff Yass fully exited iShares 20+ Year Treasury Bond ETF in Q3 2017, selling an estimated $69.3M.
  • Jeff Yass's ten largest holdings make up 24% of its $259B portfolio in Q3 2017.
  • Jeff Yass opened 1,312 new positions and closed 1,693 in Q3 2017.
  • Jeff Yass's portfolio value rose 14% quarter-over-quarter to $259B.

Based on Susquehanna International Group's 13F filing for Q3 2017, filed 14 Nov 2017.